INVESTOR RELATIONS
Be part of a technological breakthrough in fetal medicine
Raydiant Oximetry is offering its investors the chance to be part of a
fundamental transformation in obstetrics, worldwide.
THE PROBLEM
What’s at the root of rising maternal morbidity and mortality?
It’s a sobering fact that more women die of pregnancy-related complications in America than they do in any other developed country. What’s more, only in America is this death rate rising and disproportionally affecting black women – black women are 3X more likely to die in childbirth than white women.
A number of causes lie at the heart of this and Raydiant Oximetry is tackling a critical unmet need – innovative technology that directly and accurately measures fetal oxygenation during labor.
Electronic fetal monitoring
Electronic fetal monitoring is the most commonly used tool in obstetrics for over 70 years and has virtually eliminated unexpected intrapartum death, however it lacks any evidence to support its ability to reduce neonatal morbidity and mortality.
Category II tracings
Cesarean rate
The C-section rate has skyrocketed in the US since the 1970’s. One in three women will undergo a cesarean delivery and 90% of these women will have another cesarean with a subsequent pregnancy. These major abdominal surgeries carry risks such as hemorrhage, infection, sepsis and organ injury. It is estimated that half of cesareans are medically unnecessary.
Why Invest?
Novel technology
Raydiant Oximetry is poised to deliver a first-to-market commercial product that meets the goals of all its key stakeholders - patients, providers and healthcare systems.
Disrupt the standard of care
The company is targeting an FDA indication that addresses 80% of annual births.
Breakthrough status
Our technology has already received the coveted FDA Breakthrough designation and is protected by four families of patents.
Global Impact
The company is pursuing a dual market strategy to develop solutions for low and middle-income countries enabled by grants from the Bill & Melinda Gates foundation and the NIH.
Seamless integration
The technology seamlessly integrates with current FHR monitoring, causing no disruption to existing hospital workflows.
Strong support
Raydiant Oximetry has been funded by the NIH, NSF, and private accredited investors.
Current Investors
Related News
Maternal Mortality and Maternity Care in the United States Compared to 10 Other Developed Countries
Most maternal deaths are preventable, but they have been increasing in the United States. Other high-income countries with success in preventing maternal deaths offer potential lessons for the U.S.
The High Costs of Maternal Morbidity Show Why We Need Greater Investment in Maternal Health
Maternal morbidity — health conditions stemming from or worsened by pregnancy — is on the rise in the United States, disproportionately affecting people of color and those with social disadvantages.
FACT SHEET: Vice President Kamala Harris Announces Call to Action to Reduce Maternal Mortality and Morbidity
President Joe Biden and Vice President Kamala Harris have long championed policies to improve maternal health and equity, and addressing the maternal mortality and morbidity crisis is a key priority of their Administration.
FACT SHEET: President Biden’s Maternal Health Blueprint Delivers for Women, Mothers, and Families
The Biden-Harris Administration is committed to cutting the rates of maternal mortality and morbidity, reducing the disparities in maternal health outcomes, and improving the overall experience during and after pregnancy for people across the country.
Four in 5 pregnancy-related deaths in the U.S. are preventable
More than 80% of pregnancy-related deaths were preventable, according to 2017-2019 from Maternal Mortality Review Committees (MMRCs).
A woman dies every two minutes due to pregnancy or childbirth: UN agencies
New data show major setbacks for maternal health in many parts of the world, highlighting stark disparities in healthcare access.
On International Women’s Day And Every Day, Investing In Women’s Health Is An Economic Driver For All
Women are foundational to a healthier world, yet for decades, there has been a need to increase investment in the health of women.
Invest in Lumerah
Want to learn more about the investment opportunity? Send us a message and we’ll be in touch as soon as possible.